Showing 1-10 of 12 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Development of an antigen-specific lipid nanoparticle mRNA therapy for T1D | Integrated Nanotherapeutics, Inc | Chris Tam | Cures | 01-June-2024 to 30-November-2026 | $750,000.00 |
| Beta cell prohormones as biomarkers of SC-beta cell graft function in T1D | The University of British Columbia | C. Bruce Verchere | Cures | 01-January-2026 to 31-December-2026 | $299,999.83 |
| Subcellular proteomic profiling of human primary and stem cell derived beta cells: A blueprint for making better beta cells | The University of British Columbia | Haoning Cen | Cures | 01-March-2025 to 29-February-2028 | $264,895.00 |
| Image-based phenotyping of stem cell derived islets | The University of British Columbia | Hongshen Ma | Cures | 01-September-2025 to 31-August-2028 | $750,000.00 |
| BimT1D | The University of British Columbia | Jan Dutz | Cures | 01-September-2025 to 31-August-2029 | $2,488,315.00 |
| Clinical Phase II/III Trial to treat type 1 diabetes (UST1D2) | The University of British Columbia | Jan Dutz | Cures | 01-November-2020 to 31-December-2027 | $538,854.00 |
| Engineering Stem Cell-Derived Islet Organoids with Immune Protection and Enhanced Vascular Support for Functional Cure of Diabetes | The University of British Columbia | Jia Zhao | Cures | 01-March-2026 to 28-February-2029 | $285,000.00 |
| Modulation of immune cell fate and function by the islet secretome in health and diabetes | The University of British Columbia | Lauar de Brito Monteiro | Cures | 01-March-2024 to 28-February-2027 | $243,055.00 |
| Harmonizing biomarkers in clinical trials of ustekinumab | The University of British Columbia | Megan Levings | Cures | 01-July-2018 to 30-June-2027 | $660,059.94 |
| RREB1 and Ras signalling in cytokine-induced beta cell death | The University of British Columbia | Nicole Krentz | Cures | 01-March-2026 to 28-February-2031 | $1,000,000.00 |